iifl-logo

Suven Life Sciences Ltd Share Price

227.29
(0.47%)
Jun 20, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open226.23
  • Day's High230
  • 52 Wk High271.72
  • Prev. Close226.23
  • Day's Low221.26
  • 52 Wk Low 96.9
  • Turnover (lac)500.39
  • P/E0
  • Face Value1
  • Book Value36.61
  • EPS0
  • Mkt. Cap (Cr.)4,956.6
  • Div. Yield0
View All Historical Data
No Records Found

Suven Life Sciences Ltd KEY RATIOS

Sector

Healthcare

Open

226.23

Prev. Close

226.23

Turnover(Lac.)

500.39

Day's High

230

Day's Low

221.26

52 Week's High

271.72

52 Week's Low

96.9

Book Value

36.61

Face Value

1

Mkt Cap (₹ Cr.)

4,956.6

P/E

0

EPS

0

Divi. Yield

0

Suven Life Sciences Ltd Corporate Action

6 May 2024

12:00 AM

AGM

Announcement Date: 06 May, 2024

arrow

6 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

13 May 2025

12:00 AM

EGM

arrow

Suven Life Sciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Suven Life Sciences Ltd SHAREHOLDING SNAPSHOT

22 Jun, 2025|01:51 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.26%

Foreign: 0.00%

Indian: 70.26%

Non-Promoter- 0.26%

Institutions: 0.26%

Non-Institutions: 29.47%

Custodian: 0.00%

Share Price

Suven Life Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

21.81

21.81

14.54

49.65

Preference Capital

0

0

0

0

Reserves

823.57

831.64

461.44

352.01

Net Worth

845.38

853.45

475.98

401.66

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

11.84

13.47

14.41

625.25

yoy growth (%)

-12.12

-6.49

-97.69

15.03

Raw materials

0

0

0

-153.7

As % of sales

0

0

0

24.58

Employee costs

-17.46

-15.28

-14.59

-58.73

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-36.24

-27.95

-25.93

230.26

Depreciation

-4.39

-4.34

-4.16

-21.3

Tax paid

0

5.32

12.18

-71.83

Working capital

-73.46

43.42

-154.2

81.51

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-12.12

-6.49

-97.69

15.03

Op profit growth

19.95

-13.37

-115.13

40.86

EBIT growth

31.61

6.86

-110.81

42.32

Net profit growth

60.16

64.55

-108.68

28.3

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

6.66

11.69

13.54

11.84

13.48

Excise Duty

0

0

0

0

0

Net Sales

6.66

11.69

13.54

11.84

13.48

Other Operating Income

0

0

0

0

0

Other Income

10.9

28.59

14.45

5.32

7.75

Suven Life Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Max Healthcare Institute Ltd

MAXHEALTH

1,163

149.541,12,953.74177.390.13658.785.26

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

7,009.5

77.731,00,772.2333.40.42,075.3607.44

Fortis Healthcare Ltd

FORTIS

748.1

440.2656,504.84-42.230.13388.47120.19

Narayana Hrudayalaya Ltd

NH

1,873.8

88.6938,244.08159.980.24919.03106.95

Global Health Ltd

MEDANTA

1,163

62.6631,236.7193.410.04802.87130.22

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Suven Life Sciences Ltd

Management

Register Office

Registrar Office

Chairman & CEO

Venkateswarlu Jasti

Whole-time Director

Sudha Rani Jasti

Non Executive Director

Seyed E Hasnain

Independent Director

Santanu Mukherjee

Independent Director

J A S Padmaja

Company Sec. & Compli. Officer

Shrenik Soni

Independent Director

V Sambasiva Rao

Registered Office

#8-2-334 SDE Serene Chambers,

6 th Floor Road No 5 Avenue 7,

Telangana - 500034

Tel: 91-40-23541142/3311/3315

Website: http://www.suven.com

Email: info@suven.com; investorservices@suven.com

Registrar Office

Karvy Selenium Tow-B,

31&32 Financial Dist, Nanakramguda,

Hyderabad-500032

Tel: 91-40-67162222

Website: www.kfintech.com

Email: einward.ris@kfintech.com

Summary

Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limite...
Read More

Company FAQs

What is the Suven Life Sciences Ltd share price today?

The Suven Life Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹227.29 today.

What is the Market Cap of Suven Life Sciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Suven Life Sciences Ltd is ₹4956.60 Cr. as of 20 Jun ‘25

What is the PE and PB ratio of Suven Life Sciences Ltd?

The PE and PB ratios of Suven Life Sciences Ltd is 0 and 6.19 as of 20 Jun ‘25

What is the 52 Week High and Low of Suven Life Sciences Ltd?

The 52-week high/low is the highest and lowest price at which a Suven Life Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Suven Life Sciences Ltd is ₹96.9 and ₹271.72 as of 20 Jun ‘25

What is the CAGR of Suven Life Sciences Ltd?

Suven Life Sciences Ltd's CAGR for 5 Years at 47.35%, 3 Years at 56.96%, 1 Year at 134.14%, 6 Month at 59.54%, 3 Month at 82.37% and 1 Month at 8.77%.

What is the shareholding pattern of Suven Life Sciences Ltd?

The shareholding pattern of Suven Life Sciences Ltd is as follows:
Promoters - 70.27 %
Institutions - 0.26 %
Public - 29.47 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.